Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle.

about

Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle.

Item

http://www.wikidata.org/entity/Q47324492

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@en

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@nl

type

Item

label

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@en

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@nl

prefLabel

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@en

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@nl

P1476

Novel, nano-sized, liposome-en ...... integrin saturation obstacle.

@en

P2093

Da-Wei Chen

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Kang Chen

http://www.w3.org/2001/XMLSchema#string

Yan-Zhi Song

http://www.w3.org/2001/XMLSchema#string

Yi-Hui Deng

http://www.w3.org/2001/XMLSchema#string

Zhen-Jun Huang

http://www.w3.org/2001/XMLSchema#string

P2860

RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.

Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.

Causes and consequences of tumour acidity and implications for treatment.

Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy.

Cell-penetrating peptides.

Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach

PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

P304

734-746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1061186X.2017.1324860

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28452577

http://www.w3.org/2001/XMLSchema#string